Potential for Long-Term Survival With ICIs in Melanoma

A new study evaluating long-term survival in clinical practice found that most patients who achieved a complete response on first-line immune checkpoint inhibitors lived beyond 3 years.
Medscape Medical News

source https://www.medscape.com/viewarticle/potential-long-term-survival-icis-advanced-melanoma-2024a1000fln?src=rss

Comments

Popular posts from this blog

RA and RA-ILD Linked to Higher Lung Cancer Risk

A case report of pudendal arteries angioplasty with sirolimus drug-coated balloon and drug-eluting stent associated with intracavernous autologous peripheral blood mononuclear cells injection for untreatable vasculogenic erectile dysfunction.